These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16313935)

  • 41. A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.
    Mulenga M; Malunga F; Bennett S; Thuma PE; Shulman C; Fielding K; Alloueche A; Greenwood BM
    Trop Med Int Health; 2006 Nov; 11(11):1643-52. PubMed ID: 17054743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative features and outcomes of malaria at a tertiary care hospital in Karachi, Pakistan.
    Beg MA; Sani N; Mehraj V; Jafri W; Khan MA; Malik A; Menezes E; Hussain R; Smego R
    Int J Infect Dis; 2008 Jan; 12(1):37-42. PubMed ID: 17576086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Duodenal ulcers caused by chloroquine-proguanil association].
    Roux X; Imbert P; Rivière F; Méchaï F; Rapp C
    Med Trop (Mars); 2010 Dec; 70(5-6):423-4. PubMed ID: 21520638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of malaria in Zanzibar.
    Makame MH; Tull ES; Nondo HS
    East Afr Med J; 1993 Mar; 70(3):171-4. PubMed ID: 8261946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chloroquine chemoprophylaxis in children during peak transmission period in Ethiopia.
    Wolde B; Pickering J; Wotton K
    J Trop Med Hyg; 1994 Aug; 97(4):215-8. PubMed ID: 8064943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential toxicity of chlorpheniramine plus chloroquine for the treatment of childhood malaria.
    Adedapo AD; Ademowo OG; Adedapo KS; Demissie K; Osinubi OY
    Niger J Clin Pract; 2009 Sep; 12(3):252-7. PubMed ID: 19803020
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on malaria prophylaxis with chlorproguanil or chloroquine in Mozambique.
    Schapira A; Da Costa F
    Cent Afr J Med; 1988 Mar; 34(3):44-9. PubMed ID: 3071421
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of three regimens for malaria prophylaxis in travellers to east, central, and southern Africa.
    Wetsteyn JC; de Geus A
    BMJ; 1993 Oct; 307(6911):1041-3. PubMed ID: 8123120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis.
    Jiménez BC; Navarro M; Huerga H; López-Román E; Mendoza A; López-Vélez R
    J Travel Med; 2006; 13(6):373-5. PubMed ID: 17107431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pregnancy and blood parasite indices of Plasmodium falciparum (results of a study in Bangui (Central African Republic))].
    Testa J; Baquillon G; Delmont J; Kamata G; Ngama G
    Med Trop (Mars); 1987; 47(4):339-43. PubMed ID: 3323770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis.
    A-Elbasit IE; Elbashir MI; Khalil IF; Alifrangis M; Giha HA
    Trop Med Int Health; 2006 May; 11(5):604-12. PubMed ID: 16640612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-medication with chloroquine in a rural district of Tanzania: a therapeutic challenge for any future malaria treatment policy change in the country.
    Nsimba SE; Rimoy GH
    J Clin Pharm Ther; 2005 Dec; 30(6):515-9. PubMed ID: 16336283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change.
    Basco LK; Ngane VF; Ndounga M; Same-Ekobo A; Youmba JC; Abodo RT; Soula G
    Am J Trop Med Hyg; 2006 Sep; 75(3):388-95. PubMed ID: 16968911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
    van Genderen PJ; Koene HR; Spong K; Overbosch D
    J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention and morbidity of malaria in non-immune subjects; a case-control study among Italian troops in Somalia and Mozambique, 1992-1994.
    Peragallo MS; Sabatinelli G; Majori G; Calì G; Sarnicola G
    Trans R Soc Trop Med Hyg; 1997; 91(3):343-6. PubMed ID: 9231213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
    Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
    Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Falciparum malaria presenting as psychosis.
    Sowunmi A; Ohaeri JU; Falade CO
    Trop Geogr Med; 1995; 47(5):218-9. PubMed ID: 8553446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malaria chemosuppression during pregnancy. VI. Some epidemiological aspects of malaria in infants.
    Mutabingwa TK; de Geus A; Meuwissen JH; Malle LN
    Trop Geogr Med; 1994; 46(1):1-7. PubMed ID: 8165727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in antimalarial prescriptions in Australia 2002 to 2005.
    Leggat PA
    J Travel Med; 2008; 15(5):302-6. PubMed ID: 19006502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors associated with malaria treatment failures in Ibadan.
    Yusuf OB; Oladepo O; Odunbaku SO; Alaba O; Osowole OS
    Afr J Med Med Sci; 2005 Sep; 34(3):251-8. PubMed ID: 16749357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.